Mode
Text Size
Log in / Sign up

CT radiomics model predicts lymphovascular invasion in 252 colorectal cancer patientsDoctors use CT scans to spot hidden cancer spread before surgery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider CT radiomics features as potential predictors of LVI in CRC, but note observational limitations.

This retrospective cohort study assessed a CT-based radiomics model for preoperative prediction of lymphovascular invasion (LVI) in patients with colorectal cancer. The analysis included a training set of 252 patients and a validation set of 108 patients. The study setting and funding sources were not reported.

In the training set, the LVI-positive rate was 27.78% (70/252). In the validation set, the LVI-positive rate was 28.70% (31/108). P-values were mentioned but specific values were not reported for these rates.

Independent predictors of LVI identified included tumor volume, maximum tumor diameter, depth of tumor invasion, maximum short-axis diameter of regional lymph nodes, Carcinoembryonic Antigen level, Neutrophil-to-Lymphocyte Ratio (NLR), standard deviation of CT value of tumor parenyma, and Rad-score. Specific P-values for these predictors were not reported.

Safety data, adverse events, and discontinuations were not reported. Because this is an observational study, causal inferences cannot be made. The clinical utility of this model requires further validation in prospective trials.

Imagine standing in an operating room. The surgeon is about to make a big cut. They need to know exactly what they are removing. If they miss hidden cancer cells, the patient could return to the hospital soon. If they remove too much healthy tissue, the patient suffers unnecessary pain.

This is the daily dilemma for colorectal cancer teams. They often rely on a microscope to see the truth. But that truth only comes after the surgery is done.

The Hidden Danger in CT Scans

Colorectal cancer is common. It affects the large intestine and rectum. Many people live with this disease for years. Standard CT scans are great for seeing tumors. They show size and location clearly.

But there is a problem. CT scans cannot always see tiny threads of cancer. These threads travel through blood vessels. Doctors call this lymphovascular invasion, or LVI. It is a sign that cancer might spread to other parts of the body.

Currently, doctors wait for the pathology report. This report comes days after surgery. By then, the patient has already gone through a major operation. They have recovered from anesthesia and lost blood.

A New Way to See the Invisible

Researchers wanted to change this timeline. They asked a computer to help. They fed the computer thousands of CT scans. They taught it to look for subtle patterns humans miss.

Think of the CT scan like a dark room. You can see the big furniture. But you cannot see the dust motes dancing in the light. The computer learns to see those dust motes. It looks at the texture of the tumor. It checks the density of the tissue. It even looks at your blood work numbers.

How the Computer Learns

The computer uses a method called radiomics. This sounds scary, but it is just math. It breaks the image into tiny pixels. It measures how bright each pixel is. It looks for variations in color and shape.

The study looked at eight specific clues. These included the size of the tumor. It also checked the level of a protein called Carcinoembryonic Antigen. This protein often rises when cancer is present. The computer also looked at your blood cell counts.

The team studied 252 patients. They split the group into two parts. One part taught the computer. The other part tested it. The computer guessed the LVI status correctly most of the time.

In the test group, the computer was very accurate. It identified the patients who had hidden spread. It did this without needing to wait for the microscope. This gives doctors a head start. They can plan the surgery differently. They might remove lymph nodes more carefully. Or they might recommend extra treatment sooner.

But there's a catch.

This tool is not ready for every hospital yet. It needs more proof. The study used data from one group of patients. Real hospitals have different machines and different patients. The computer must learn on many different types of scanners.

If you have colorectal cancer, talk to your doctor about imaging. Ask if your hospital uses advanced analysis. These tools are growing fast. They help doctors make smarter choices.

You do not need to understand the math. You just need to know that better tools are coming. They aim to give you a clearer picture before the knife touches you. This reduces risk and anxiety.

This research is just the beginning. Scientists will test this on more patients. They will check if it works on different types of CT machines. If it passes these tests, it could become standard care.

Until then, the old way remains the gold standard. Pathology reports are still the final word. But this new model is a powerful helper. It turns a standard scan into a detailed map. It shows the hidden dangers before the surgery begins.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveThis study aimed to develop and validate a computed tomography (CT)-based radiomics nomogram for the preoperative prediction of lymphovascular invasion (LVI) in colorectal cancer (CRC).MethodsIn this retrospective study, CRC patients were randomly partitioned into training and validation sets at a 7:3 ratio, and were classified as LVI-positive or LVI-negative based on postoperative histopathology. In the training set, univariate analysis, Least Absolute Shrinkage and Selection Operator (LASSO), and multivariate Logistic regression analysis were used to identify the influencing factors of LVI. A combined nomogram integrating the predictors was developed. Model discrimination was evaluated using the area under the receiver operating characteristic curve (AUC). Calibration and clinical utility were assessed with calibration curves and decision curve analysis (DCA), respectively.ResultsAmong the 252 patients in the training set, 70 (27.78%) were LVI-positive. In the validation set of 108 patients, 31 (28.70%) were LVI-positive. Multivariate analysis identified the tumor volume, maximum tumor diameter, depth of tumor invasion, maximum short-axis diameter of regional lymph nodes, Carcinoembryonic Antigen level, Neutrophil-to-Lymphocyte Ratio (NLR), standard deviation of CT value of tumor parenchyma, and Rad-score as independent predictors of LVI (P
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.